 |
PDBsum entry 3qd3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
3qd3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Structure-Based design of potent and selective 3-Phosphoinositide-Dependent kinase-1 (pdk1) inhibitors.
|
|
|
Authors
|
|
J.R.Medina,
C.J.Becker,
C.W.Blackledge,
C.Duquenne,
Y.Feng,
S.W.Grant,
D.Heerding,
W.H.Li,
W.H.Miller,
S.P.Romeril,
D.Scherzer,
A.Shu,
M.A.Bobko,
A.R.Chadderton,
M.Dumble,
C.M.Gardiner,
S.Gilbert,
Q.Liu,
S.K.Rabindran,
V.Sudakin,
H.Xiang,
P.G.Brady,
N.Campobasso,
P.Ward,
J.M.Axten.
|
|
|
Ref.
|
|
J Med Chem, 2011,
54,
1871-1895.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
Secondary reference #1
|
|
|
Title
|
|
Aminoindazole pdk1 inhibitors: a case study in fragment-Based drug discovery
|
|
|
Authors
|
|
J.R.Medina,
C.W.Blackledge,
D.A.Heerding,
N.Campobasso,
Pj.Briand,
L.Wright,
J.M.Axten.
|
|
|
Ref.
|
|
acs med chem lett, 2010,
1,
439.
|
|
|
|
|
|
|
|
